Compare · head to head
Astellas Pharma vs Handok
Astellas Pharma ranks higher overall — 360 rank 100 vs 15.
Astellas Pharma leads on Value (85 vs 51), Quality (75 vs 52), Safety (66 vs 16) and Sentiment (50 vs 40).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Japan | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | X-Large | Small |
| ISIN | JP3942400007 | KR7002390003 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 100 | 15 |
| Value | 85 | 51 |
| Quality | 75 | 52 |
| Growth | 62 | NR |
| Safety | 66 | 16 |
| Sentiment | 50 | 40 |
| Quality details | ||
| Profitability | 69 | 52 |
| Cash Truth | 81 | 51 |
Astellas Pharma vs Yuyu PharmaAstellas Pharma vs WuXi Biologics (Cayman)Astellas Pharma vs Whanin PharmAstellas Pharma vs Sino BiopharmaceuticalAdd a third stock →
Full analyses: Astellas Pharma · Handok
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100